NYSE:HL
NYSE:HLMetals and Mining

How Investors May Respond To Hecla Mining (HL) Raising 2025 Gold and Silver Production Guidance

Hecla Mining Company recently reported strong second quarter results, with sales of US$304.03 million and net income of US$57.71 million, both up from the previous year, and announced raised production guidance for 2025. The company's higher gold output and upwardly revised annual gold and silver production targets point to robust operational momentum and a more optimistic outlook. We’ll explore how Hecla’s raised 2025 production guidance could reshape its investment narrative and outlook...
NYSE:TPC
NYSE:TPCConstruction

Is Tutor Perini’s Upbeat Earnings Outlook Reshaping the Long-Term Growth Narrative for TPC?

On August 6, 2025, Tutor Perini Corporation reported that second quarter sales increased to US$1.37 billion and net income rose to US$19.97 million, with the company also raising its GAAP EPS guidance for 2025 and projecting higher earnings for 2026 and 2027. This marks a significant shift from the prior year, with both quarterly and year-to-date results showing substantial growth in sales and profits, as well as renewed confidence in future performance. We'll explore how Tutor...
NYSE:ECVT
NYSE:ECVTChemicals

Ecovyst’s Share Buybacks and Updated Guidance Might Change the Case for Investing in ECVT

Ecovyst Inc. recently reported its second quarter 2025 earnings, completed a share repurchase of over 2.9 million shares for US$21.85 million, and provided updated full-year sales guidance of US$795 million to US$835 million, alongside improved expectations for its Zeolyst joint venture. An important development is the completion of a significant share buyback program, totaling more than 27.4 million shares repurchased since 2022, representing a substantial return of capital to...
NYSE:JPM
NYSE:JPMBanks

JPMorgan Chase (JPM): Is There Hidden Value in Its Current Stock Price?

JPMorgan Chase (JPM) has edged higher in recent days, landing on the radar for many investors looking to assess their next move in the banking sector. The bank’s modest price uptick has not been sparked by any headlines or dramatic earnings beats. Instead, it seems to reflect a confluence of steady business results and cautious optimism in the broader financial markets. When nothing dramatic makes the news, it often pays to look a little deeper, especially for a bank as influential as...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

Will a $1.3 Billion Debt Offering Reshape Gaming and Leisure Properties' (GLPI) Growth Outlook?

Gaming and Leisure Properties, Inc. recently announced the pricing of a public offering of US$1.30 billion in senior notes to be issued by its operating partnership and a wholly-owned subsidiary, with proceeds intended to redeem existing 2026 notes and support working capital, development, and expansion projects. This substantial capital-raising initiative signals an ongoing effort to optimize the company’s debt structure while funding future growth opportunities. We’ll examine how this...
NYSE:BA
NYSE:BAAerospace & Defense

Should You Revisit Boeing After Shares Jump 35% Amid Commercial Plane Order Surge?

Thinking about what to do with Boeing stock right now? You are not alone. The past year has been a roller coaster, and investors have been watching every twist and turn with keen interest. After a dip earlier in the year, Boeing has rebounded, with shares up nearly 35% year-to-date and notching a 12% gain just in the past three months. That kind of momentum is hard to ignore, especially when you consider that the broader market has dealt with its fair share of turbulence. So, what is driving...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Stoke Therapeutics (STOK) Is Up 40.7% After Biogen Partnership and Positive Phase 3, Sales Milestone

Stoke Therapeutics and Biogen announced that the first patient has been dosed in the global Phase 3 EMPEROR study of zorevunersen for Dravet syndrome, launching a key late-stage trial with sites in the United States, United Kingdom, and Japan and plans for Europe. Alongside this clinical milestone, Stoke Therapeutics reported a very large year-over-year increase in sales and achieved net income of US$89.4 million for the first half of 2025, compared to a net loss in the prior year. We'll...
NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

DXP Enterprises (DXPE) Is Up 5.3% After Strong Q2 Earnings and Expanded Acquisition Plans Has the Bull Case Changed?

DXP Enterprises, Inc. reported strong second quarter 2025 earnings, with sales rising to US$498.68 million and net income reaching US$23.61 million, both significantly above the prior year’s results. During the same period, management disclosed undrawn credit lines and increased liquidity, positioning the company to pursue at least three to four acquisitions in the second half of the year. We'll examine how DXP's strengthened balance sheet and acquisition pipeline may impact its outlook and...
NasdaqGM:LUNR
NasdaqGM:LUNRAerospace & Defense

Intuitive Machines (LUNR) Sees US$38 Million Net Loss In Recent Quarterly Performance

Intuitive Machines (LUNR) reported a notable quarterly performance on August 7, 2025, with sales increasing to $50.31 million, but a net loss of $38.59 million contrasted sharply with last year's profit. Despite securing a $9.8 million government contract and pursuing strategic mergers and acquisitions, the company's share price dropped 10.49% last week. This decline occurred as major indexes like the Dow and S&P 500 hovered near record highs, closing with slight gains over the same period...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

USA Rare Earth (USAR) Reports Net Loss of US$143M for Q2 2025

USA Rare Earth (USAR) recently reported a net loss of USD 143 million for Q2 2025, signaling financial hurdles. However, a notable 82% rise in its share price last quarter coincides with strategic partnerships, including an MOU with Enduro Pipeline Services and a joint development agreement with ePropelled to produce neo magnets, reinforcing growth prospects despite market volatility. Concurrently, broader market trends saw marginal dips in major indices as stocks hovered near record highs...
NasdaqGM:GAMB
NasdaqGM:GAMBMedia

Gambling.com Group (GAMB) Expands Equity Buyback Plan By US$10 Million

Last week, Gambling.com Group (GAMB) reported its Q2 2025 earnings, which showed promising sales growth from $30.54 million to $39.59 million year-over-year, but also revealed a net loss of $13.42 million against a previous net income of $6.93 million. Additionally, the company expanded its equity buyback plan by $10 million. Despite these moves, GAMB's stock fell by 14%. This decline contrasts with broader market trends where major indices hovered near record highs and posted gains for a...
NYSE:GLOB
NYSE:GLOBIT

Globant (GLOB) Experiences 11% Drop Over Last Week

Globant (GLOB) is experiencing a period of pivotal developments, marked by new updates to its AI platform and the resignation of COO Patricia Pomies. However, the company's share price observed a 10.88% decline last week. This downturn coincided with a modest 1.3% overall market increase, leaving the company at odds with broader trends. Globant's recent product enhancements, which promise significant operational efficiency, and the anticipation of upcoming earnings results, may have added...